Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 10, 2022
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
[ Wed, Aug 10th 2022
] - WOPRAI
Drew Ranieri Maintained (TMCI) at Buy with Increased Target to $23 on, Aug 10th, 2022
Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Buy with Increased Target from $22 to $23 on, Aug 10th, 2022.
Drew has made no other calls on TMCI in the last 4 months.
There are 2 other peers that have a rating on TMCI. Out of the 2 peers that are also analyzing TMCI, 0 agree with Drew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Drew
- Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $21 on, Monday, July 18th, 2022
- Ryan Zimmerman of "BTIG" Initiated at Strong Buy and Held Target at $22 on, Thursday, May 12th, 2022
